These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31000432)

  • 21. [Prevention of complications after percutaneous coronary interventions with statins].
    Mega S; Nusca A; Patti G
    Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris.
    Hirayama K; Ota T; Harada K; Shibata Y; Tatami Y; Harata S; Kawashima K; Kunimura A; Shimbo Y; Takayama Y; Kawamiya T; Yamamoto D; Osugi N; Suzuki S; Ishii H; Murohara T
    Clin Ther; 2017 Feb; 39(2):279-287. PubMed ID: 28034517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins, percutaneous coronary intervention and myocardial infarction.
    Jones A
    Curr Med Res Opin; 2014 Mar; 30(3):387-9. PubMed ID: 24020882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.
    Patti G; Cannon CP; Murphy SA; Mega S; Pasceri V; Briguori C; Colombo A; Yun KH; Jeong MH; Kim JS; Choi D; Bozbas H; Kinoshita M; Fukuda K; Jia XW; Hara H; Cay S; Di Sciascio G
    Circulation; 2011 Apr; 123(15):1622-32. PubMed ID: 21464051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Ndrepepa G; King L; Cassese S; Fusaro M; Tada T; Schömig A; Kastrati A
    Eur J Intern Med; 2013 Mar; 24(2):145-50. PubMed ID: 23182629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
    Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
    Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
    Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
    Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-Term Statin Adherence in Patients with Stable Angina after Coronary Stenting].
    Tomilova DI; Karpov YA; Lopukhova VV
    Kardiologiia; 2018 May; (5):65-71. PubMed ID: 29870326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovičová L; Tomašov P; Tesař D
    Am J Cardiol; 2011 May; 107(9):1295-9. PubMed ID: 21349484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials.
    D'Ascenzo F; Barbero U; Moretti C; Palmerini T; Della Riva D; Mariani A; Omedè P; DiNicolantonio JJ; Biondi-Zoccai G; Gaita F
    Contemp Clin Trials; 2014 May; 38(1):51-8. PubMed ID: 24657881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris.
    Thomas S; Gokhale R; Boden WE; Devereaux PJ
    Can J Cardiol; 2013 Apr; 29(4):472-82. PubMed ID: 23010084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
    Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
    BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention.
    Auguadro C; Manfredi M; Scalise F; Mortara A; Specchia G
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):416-21. PubMed ID: 16721204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D; Bybee KA
    Heart Vessels; 2006 May; 21(3):146-51. PubMed ID: 16715188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.